SeaCrest Wealth Management’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-11,036
| Closed | -$348K | – | 678 |
|
|
2022
Q2 | $348K | Buy |
11,036
+6,208
| +129% | +$196K | 0.04% | 433 |
|
|
2022
Q1 | $222K | Buy |
4,828
+505
| +12% | +$23.2K | 0.03% | 621 |
|
|
2021
Q4 | $265K | Sell |
4,323
-238
| -5% | -$14.6K | 0.03% | 552 |
|
|
2021
Q3 | $341K | Buy |
4,561
+2,041
| +81% | +$153K | 0.04% | 461 |
|
|
2021
Q2 | $233K | Sell |
2,520
-4,763
| -65% | -$440K | 0.03% | 585 |
|
|
2021
Q1 | $646K | Buy |
7,283
+1,018
| +16% | +$90.3K | 0.09% | 252 |
|
|
2020
Q4 | $584K | Sell |
6,265
-754
| -11% | -$70.3K | 0.08% | 256 |
|
|
2020
Q3 | $447K | Sell |
7,019
-1,355
| -16% | -$86.3K | 0.07% | 272 |
|
|
2020
Q2 | $437K | Sell |
8,374
-7,948
| -49% | -$415K | 0.08% | 276 |
|
|
2020
Q1 | $511K | Sell |
16,322
-2,608
| -14% | -$81.7K | 0.11% | 204 |
|
|
2019
Q4 | $635K | Sell |
18,930
-6,118
| -24% | -$205K | 0.11% | 226 |
|
|
2019
Q3 | $739K | Sell |
25,048
-8,958
| -26% | -$264K | 0.14% | 189 |
|
|
2019
Q2 | $1.17M | Buy |
34,006
+16,678
| +96% | +$575K | 0.24% | 96 |
|
|
2019
Q1 | $570K | Sell |
17,328
-2,380
| -12% | -$78.3K | 0.1% | 207 |
|
|
2018
Q4 | $473K | Sell |
19,708
-7,433
| -27% | -$178K | 0.1% | 215 |
|
|
2018
Q3 | $907K | Buy |
27,141
+5,054
| +23% | +$169K | 0.15% | 135 |
|
|
2018
Q2 | $642K | Buy |
+22,087
| New | +$642K | 0.12% | 187 |
|